DrugPatentWatch Database Preview
Profile for China Patent: 102127080
US Patent Family Members and Approved Drugs for China Patent: 102127080
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Nov 26, 2025 | Boehringer Ingelheim | JENTADUETO XR | linagliptin; metformin hydrochloride |
➤ Sign Up | Nov 26, 2025 | Boehringer Ingelheim | GLYXAMBI | empagliflozin; linagliptin |
➤ Sign Up | Nov 26, 2025 | Boehringer Ingelheim | JENTADUETO | linagliptin; metformin hydrochloride |
➤ Sign Up | Nov 26, 2025 | Boehringer Ingelheim | TRADJENTA | linagliptin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |